Maximizing SPECTRALIS in the Detection and Interpretation of Ocular Biomarkers | SPECTRALIS

Andrew Rixon, OD, FAAO, Diplomate (Glaucoma) leads this complimentary webinar on the intricacies of ocular biomarkers, detection, and interpretation using OCT. Dr. Rixon empowers attendees to use cross-sectional OCT in detecting retinal biomarkers consistent with AMD, diabetes, and glaucoma and implementing their use prognostically, discusses how serial RNFL analysis can be beneficial in clinic to determine evolution of disease and helps participants evaluate the value of fundus autofluorescence and OCT angiography in retinal disease. CHAPTERS 00:00 – Introduction 01:51 – Objectives: Biomarkers and Multimodal Imaging in AMD, DR and Glaucoma 02:46 – What's a Biomarker? 04:42 – AMD Biomarkers 37:55 – Glaucoma Biomarkers 50:02 – Diabetic Biomarkers 54:42 – Questions _________________________________________________________________________________ FOLLOW US ON » Instagram: https://www.instagram.com/heidelbergengineering » Linkedin: https://www.linkedin.com/company/heidelberg-engineering MORE INFORMATION » Website: https://www.heidelbergengineering.com/ » Academy: https://he-academy.com » Know the Eye: https://www.know-the-eye.com/ » Imprint: https://business-lounge.heidelbergengineering.com/legal-information/publisher/ » Privacy Police: https://www.heidelbergengineering.com/int/privacy-policy-for-the-social-media-appearances-of-heidelberg-engineering-gmbh/ 𝙉𝙤𝙩 𝙖𝙡𝙡 𝙛𝙚𝙖𝙩𝙪𝙧𝙚𝙨/𝙢𝙤𝙙𝙪𝙡𝙚𝙨 𝙤𝙛 𝙩𝙝𝙚 𝙥𝙧𝙤𝙙𝙪𝙘𝙩 𝙢𝙞𝙜𝙝𝙩 𝙗𝙚 𝙖𝙫𝙖𝙞𝙡𝙖𝙗𝙡𝙚 𝙞𝙣 𝙮𝙤𝙪𝙧 𝙘𝙤𝙪𝙣𝙩𝙧𝙮. 𝙁𝙞𝙣𝙙 𝙢𝙤𝙧𝙚 𝙞𝙣𝙛𝙤𝙧𝙢𝙖𝙩𝙞𝙤𝙣 𝙖𝙗𝙤𝙪𝙩 𝙖𝙫𝙖𝙞𝙡𝙖𝙗𝙞𝙡𝙞𝙩𝙮 𝙤𝙣 https://business-lounge.heidelbergengineering.com/redirect/products/